New posts are up on Life Sciences Legal Update regarding a Senate committee hearing on DTC ads for medical devices, the DOJ’s revised its Principles of Federal Prosecution of Business Organizations, the business climate for pharmaceutical manufacturers, House Energy and Commerce Committee action on more than 7 health policy bills, and the overlooked implications of the FTC’s Red Flag Regulations for the life sciences and health care industry. These posts, and more, are in keeping with the site’s inter-disciplinary scope which is grounded in the recognition that legal issues are intertwined with business concerns, and rarely confine themselves to narrowly proscribed practice areas.
